The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study
NCT: NCT05409976 · ACTIVE_NOT_RECRUITING
Brief Summary
This study is a prospective, multicenter, non-randomized, single-arm study to evaluate the performance, safety, and efficacy of the GORE® VIABAHN® FORTEGRA Venous Stent (formerly known as GORE® VIAFORT Vascular Stent) for treatment of symptomatic inferior vena cava obstruction with or without combined iliofemoral obstruction in adult patients.
Frequently Asked Questions
What is The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study?
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study is a clinical trial registered under NCT05409976. Current status: ACTIVE_NOT_RECRUITING.
What is the status of NCT05409976?
The current status of NCT05409976 (The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study) is: ACTIVE_NOT_RECRUITING.
When did The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study start?
The GORE® VIABAHN® FORTEGRA Venous Stent IVC Study started on 2022-10-25.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.